AFT Pharmaceuticals enters exclusive development, license and supply agreement with Mikasaseiyaku
AFT grants Mikasaseiyaku an exclusive licence to seek marketing authorisation and commercialise Maxigesic IV in Japan.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
AFT Pharmaceuticals Enters Exclusive Development, License And Supply Agreement With Mikasaseiyaku
AFT Pharmaceuticals Ltd NZX:AFT